Position in RDNT
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$329,934
+$30,923 QoQ
Shares Held
5,350
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#212
of 327 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Yorktown Management & Research Co Inc holds $4,944,899 across 7 Diagnostics & Research names. RDNT ranks #7 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
12,500 | $1,875,375 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
1,800 | $953,262 | |
| 3 | TWST |
Twist Bioscience Corp
|
5,100 | $524,688 | |
| 4 | VCYT |
Veracyte, Inc.
|
7,750 | $455,157 | |
| 5 | BLLN |
BillionToOne, Inc.
|
3,450 | $413,931 | |
| 6 | GRAL |
GRAIL, Inc.
|
5,750 | $392,552 | |
| 7 | RDNT |
RadNet, Inc.
This page
|
5,350 | $329,934 |
All Filings in RDNT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $329,934 | 5,350 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $299,011 | 5,350 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $381,722 | 5,350 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $407,723 | 5,350 | Shares | Sole | 2025-10-29 | |
| 2024-12-31 | $272,376 | 3,900 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $270,621 | 3,900 | Shares | Sole | 2024-10-25 | |
| 2023-12-31 | $678,015 | 19,500 | Shares | Sole | 2024-01-26 | |
| No filing history on record for this holder in this stock. | ||||||